A detailed history of Castleview Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Castleview Partners, LLC holds 2,927 shares of ZTS stock, worth $517,317. This represents 0.4% of its overall portfolio holdings.

Number of Shares
2,927
Previous 2,929 0.07%
Holding current value
$517,317
Previous $572,000 0.17%
% of portfolio
0.4%
Previous 0.38%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$172.58 - $196.48 $345 - $392
-2 Reduced 0.07%
2,927 $571,000
Q2 2024

Jul 31, 2024

SELL
$145.54 - $178.83 $17,464 - $21,459
-120 Reduced 3.94%
2,929 $507,000
Q1 2024

May 09, 2024

BUY
$165.67 - $199.94 $136,180 - $164,350
822 Added 36.91%
3,049 $515,000
Q4 2023

Feb 05, 2024

BUY
$151.44 - $200.09 $15,144 - $20,009
100 Added 4.7%
2,227 $439,000
Q3 2023

Oct 26, 2023

SELL
$167.14 - $192.77 $3,509 - $4,048
-21 Reduced 0.98%
2,127 $370,000
Q2 2023

Aug 14, 2023

SELL
$160.94 - $186.23 $45,063 - $52,144
-280 Reduced 11.53%
2,148 $369,000
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $8,001 - $9,626
-55 Reduced 2.22%
2,428 $404,000
Q4 2022

Feb 01, 2023

SELL
$131.14 - $157.47 $9,179 - $11,022
-70 Reduced 2.74%
2,483 $363,000
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $201,377 - $247,902
-1,358 Reduced 34.72%
2,553 $379,000
Q2 2022

Aug 17, 2022

SELL
$155.97 - $200.09 $69.2 Million - $88.8 Million
-443,690 Reduced 99.13%
3,911 $672,000
Q2 2022

Aug 16, 2022

BUY
$155.97 - $200.09 $69.4 Million - $89 Million
445,024 Added 17269.07%
447,601 $76.9 Million
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $265 Million - $342 Million
-1,461,757 Reduced 99.82%
2,577 $485,000
Q4 2021

Feb 17, 2022

BUY
$193.69 - $247.03 $282 Million - $360 Million
1,458,423 Added 24673.03%
1,464,334 $357 Million
Q2 2021

Aug 17, 2021

BUY
$155.9 - $187.99 $921,524 - $1.11 Million
5,911 New
5,911 $1.1 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.